Clinical Trials Directory

Trials / Completed

CompletedNCT04514380

Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients

Ultrasound Assessment of Gastric Volume in Elderly Patients Undergoing Total Knee Arthroplasty After Drinking Carbohydrate-containing Fluids: A Prospective Observational Non-randomized Comparative Study

Status
Completed
Phase
Study type
Observational
Enrollment
64 (actual)
Sponsor
Seoul National University Bundang Hospital · Academic / Other
Sex
All
Age
65 Years – 85 Years
Healthy volunteers
Not accepted

Summary

In the past, some guidelines advised no oral intake for at least 8 hours before any surgery. However, research has shown risks associated with excessive fasting, such as postoperative insulin resistance, and advantages in shorter fasting protocols, such as reduced postoperative nausea and vomiting. The perioperative fasting guidelines of the European Society of Anaesthesiology focus on preoperative carbohydrates. They hold that it is safe for patients to drink carbohydrate-rich fluids up to 2 hours before elective surgery and that drinking carbohydrate-rich fluids improves subjective well-being, reduces thirst and hunger, and reduces postoperative insulin resistance at an evidence level of 1++. Nevertheless, data on drinking carbohydrate fluids before surgery in elderly patients are limited. In our institution, there are two clinical pathways for total knee arthroplasty according to the surgeons. One difference is whether carbohydrate fluids drink or not before surgery. The purpose of this study, therefore, is to assess gastric volume in fasted elderly patients using ultrasound after they drank carbohydrate fluids 2 hours before surgery and to compare with matched patients using age, body mass index, and comorbidity, who did not drink carbohydrate fluids before surgery.

Conditions

Interventions

TypeNameDescription
OTHERCarbohydrate fluid400 mL carbohydrate fluid
OTHERNon-carbohydrate fluid0 mL carbohydrate fluid

Timeline

Start date
2020-09-16
Primary completion
2021-03-19
Completion
2021-03-19
First posted
2020-08-14
Last updated
2021-03-22

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04514380. Inclusion in this directory is not an endorsement.